Navigation Links
Spike in testicular cancer is focus

Pinpointing reasons behind the dramatic increase in testicular cancer, now the most common malignant cancer among 15-to-35-year-old Caucasian men, is the focus of a five-year, $5.5 million National Cancer Institute (NCI) grant to Yale Public Health researcher Tongzhang Zheng.

Testicular cancer is increasing for unknown reasons and this study will provide important information on possible environmental, genetic and other risk factors,?said Zheng, professor and head of the Division of Environmental Health Sciences in the Department of Epidemiology and Public Health at Yale School of Medicine.

Zheng will collaborate with researchers at Harvard School of Public Health and the Fred Hutchinson Cancer Research Center to conduct a population-based, case-control study on men in Connecticut and Massachusetts. The researchers will determine whether exposure to environmental factors such as environmental hormone disruptors increases the risk of testicular cancer. They will measure the levels of these environmental compounds in 800 patients with testicular cancer and in an equal number of unaffected control subjects.

Because so little is known about the potential environmental causes of testicular cancer, Zheng said, the team will collect and evaluate information on various major suspected risk factors, such as past medical history, history of hernia, venereal diseases, and any medication with androgens and other hormones. They will also examine lifetime occupational history, tobacco smoking, alcohol consumption and dietary information.

“Recent studies show that environmental exposures may affect development of testicular cancer,?said Zheng. “Determining risk factors that lead to testicular cancer, however is complicated because genetic susceptibility may modify a person’s risk from environmental exposures. We will try to assess the potential gene environment interaction on the manifestations of the disease.?


'"/>

Source:Yale University


Page: 1

Related biology news :

1. Study hints at role of stem cell genes in testicular, breast cancers
2. Viral DNA sequence a possible trigger for breast cancer
3. Enzyme, lost in most mammals, is shown to protect against UV-induced skin cancer
4. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
5. Columbia research lifts major hurdle to gene therapy for cancer
6. Combination therapy boosts effectiveness of telomere-directed cancer cell death
7. Mitochondrial DNA mutations play significant role in prostate cancer
8. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
9. BRCA1 causes ovarian cancer through indirect, biochemical route
10. Researchers identify target for cancer drugs
11. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Spike testicular cancer focus

(Date:7/31/2015)... 31. Juli 2015 Die 10. internationale Konferenz zu ... veranstaltet und findet vom 22. bis 25. Oktober ... statt. Die Konferenz feiert in ... 2006 ist die ICG weltweit zu einem der ... ist eines der dynamischsten, enthusiastischsten und angenehmsten wissenschaftlichen ...
(Date:7/31/2015)... The 10 th International Conference on Genomics (ICG-10, ... in Shenzhen , China ... anniversary this year. Since its inauguration in 2006, ICG ... in the ,omics, fields, and is one of the most ... focuses on recent breakthroughs and advances in ,omics, research that ...
(Date:7/27/2015)... Calif. , July 27, 2015  Synaptics ... of human interface solutions, today announced that Huawei ... touchscreen solution for its stylish smartwatch. Huawei ... its proven reliability, low power and highly responsive ... wet finger. Huawei designers also required a classic ...
Breaking Biology News(10 mins):Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3The 10th International Conference on Genomics (ICG-10) to Open in October 2Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3
... Society for Prevention Research (SPR) will hold its annual ... New Jersey Avenue, NW, Washington, D.C., 20001. The ... Reporters can reach authors by registering (free) for the ... 703-615-2466 to schedule media interviews anytime during the meeting. ...
... increase in Hawaii,s mountains, deadly non-native bird diseases ... most of the last disease-free refuges for honeycreepers ... A just-published U.S. Geological Survey (USGS) ... invasion" by examining the present altitudinal range of ...
... disordered may in fact have an unexpected biological role ... study published by researchers at Fox Chase Cancer Center in ... Press). The researchers published the first comprehensive structural ... of bringing together molecular signals between the outer membrane of ...
Cached Biology News:Society for Prevention Research Meeting in Washington, D.C., May 27-29, 2009 2Society for Prevention Research Meeting in Washington, D.C., May 27-29, 2009 3Jeepers creepers: Climate change threatens endangered honeycreepers 2Jeepers creepers: Climate change threatens endangered honeycreepers 3'Disordered' amino acids may really be there to provide wiggle room for signaling protein 2'Disordered' amino acids may really be there to provide wiggle room for signaling protein 3
(Date:8/4/2015)... ... August 04, 2015 , ... ... pumps and process equipment, announces the appointment of Dennis Rawle as European Director ... industrial industries. Most recently, he was General Manager and Technical Sales Manager for ...
(Date:8/4/2015)... , August 4, 2015 ... Allied Market Research, titled, "World Cardiac Biomarker - ... biomarker market would generate the revenue of $2,085.9 ... from 2015 to 2020. Cardiac Troponins (T, I) ... forecast period due to high sensitivity and specificity. ...
(Date:8/4/2015)... , Aug. 4, 2015 Trigemina, Inc., a ... non-narcotic, nasally delivered, analgesic drug products, announced today that ... the position of chief medical officer. Dr. Kori brings ... much of which has been focused in the neuroscience ... add Dr. Kori to our clinical team given his ...
(Date:8/4/2015)... ... August 04, 2015 , ... RPS Diagnostics ... – today announced that Robert A. Gregg, PhD, has joined RPS as Senior ... years of relevant experience and remarkable achievements in the medical device and diagnostics ...
Breaking Biology Technology:Dennis Rawle Joins Graphite Metallizing Corporation 2Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 2Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 3Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 4Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 5Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer 2Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer 3RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 2RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 3
... PROVIDENCE, N.J., June 8, 2011 ... eClinical technology, announced today it will preview its forthcoming ... Information Association (DIA) Annual Meeting in Chicago, IL. Guided ... simplify and streamline the startup of electronic trials. It ...
... Telik, Inc. (Nasdaq: TELK ) today announced the ... Telintra in patients with Revlimid refractory or resistant, deletion 5q ... multicenter trial intended to enroll up to 117 evaluable patients. ... patients are transfusion dependent with Low to Intermediate-1 Risk MDS. ...
... Infrared Systems International (OTCBB: IFRS) is pleased to announce that ... its NatuRx™ HIV/AIDS treatment and will push forward with clinical ... a pilot study with two HIV/AIDS patients this week which ... reported AIDS victims on June 5th, 1981. "The ...
Cached Biology Technology:Cmed Technology to Preview New Innovations to Speed and Streamline Electronic Trials at DIA Conference 2Cmed Technology to Preview New Innovations to Speed and Streamline Electronic Trials at DIA Conference 3Telik Announces Initiation of a Phase 2 Clinical Trial of Telintra® (Ezatiostat HCl) in Patients With Revlimid® Refractory or Resistant Deletion 5q Myelodysplastic Syndrome 2Telik Announces Initiation of a Phase 2 Clinical Trial of Telintra® (Ezatiostat HCl) in Patients With Revlimid® Refractory or Resistant Deletion 5q Myelodysplastic Syndrome 3Infrared Systems International's Subsidiary, AquaLiv, Inc., Strives to Be a Game Changer in Fight Against HIV/AIDS 2Infrared Systems International's Subsidiary, AquaLiv, Inc., Strives to Be a Game Changer in Fight Against HIV/AIDS 3
Human MFRP MAb (Clone 291218)...
Human RELT/TNFRSF19L MAb (Clone 238104)...
...
... assay kit measures NOS activity by monitoring ... This assay is simple, sensitive, and specific ... with both crude and purified enzyme preparations. ... for 50 total reactions. Radiolabeled arginine and ...
Biology Products: